NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE
1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature
of Operations and Organization
Indoor
Harvest Corp (the “Company,”) is a Texas corporation formed on November 23, 2011. Our principal executive office is
located at 7401 W. Slaughter Lane #5078, Austin, Texas 78739. On August 3, 2017, we formed Alamo Acquisition, LLC, a wholly owned
Texas limited liability company (“Alamo Acquisition Sub”). On August 4, 2017, we consummated a business acquisition
(the “Alamo Acquisition”) pursuant to which Alamo Acquisition Sub acquired all of the outstanding member interests
of Alamo CBD, LLC. (“Alamo CBD”), a Texas limited Liability Company. Upon closing of the Alamo Acquisition, the member
interests of Alamo CBD were exchanged for 7,584,008 shares of Indoor Harvest’s common stock, the parent company of Alamo
Acquisition Sub, and Alamo CBD continued as our surviving wholly-owned subsidiary, and Alamo Acquisition Sub ceased to exist.
Pursuant to ASC 805 “Business Combinations,” the Company determined the Alamo Acquisition was an
asset purchase.
From
inception until August 4, 2017, the Company provided full service, state of the art design-build, engineering, procurement and
construction services to the indoor and vertical farming industry. The Company provided production platforms, mechanical systems
and complete custom designed build outs for both Controlled Environment Agriculture (“CEA”) and Building Integrated
Agriculture (“BIA”), for two unique industries, produce and cannabis. In mid-2016, the Company began efforts to separate
its produce and cannabis related operations due to ongoing feedback from both clients and potential institutional investors. It
was determined that the Company’s involvement in the cannabis industry was creating conflicts for clients and potential
institutional investors wishing to work with the Company from the produce industry due to the public perception and political
issues surrounding the cannabis industry. By late-2016, the Company had decided to cease actively selling its products and services
to the vertical farming industry and to focus on utilizing the Company’s developed technology and methods for the cannabis
industry. On August 4, 2017, the Company ceased actively supporting business development of vertical farms for produce production.
Basis
of Presentation
The
accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles
generally accepted in the United States of America (“GAAP”).
It
is management’s opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been
made which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative
of the results to be expected for the year.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those
estimates.
Significant
estimates include, but are not limited to, the estimate of percentage of completion on construction contracts in progress at each
reporting period which we rely on as a primary basis of revenue recognition, estimated useful lives of equipment for purposes
of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.
Principles
of Consolidation
The
consolidated financial statements include the accounts of Indoor Harvest Corp. and its wholly-owned subsidiary, Alamo CBD. All
significant inter-company accounts and transactions have been eliminated in consolidation.
Loss
per Share
Basic
earnings (loss) per share amounts are calculated based on the weighted average number of shares of common stock outstanding during
each period. Diluted earnings (loss) per share is based on the weighted average numbers of shares of common stock outstanding
for the periods, including dilutive effects of stock options, warrants granted and convertible preferred stock. Dilutive options
and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations
for the time they were outstanding during the periods being reported. Since Indoor Harvest has incurred losses for all periods,
the impact of the common stock equivalents would be anti- dilutive and therefore are not included in the calculation.
Fair
Value of Financial Instruments
As
defined in ASC 820” Fair Value Measurements,” fair value is the price that would be received to sell
an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price).
The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including
assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable,
market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those
inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and
the lowest priority to unobservable inputs (level 3 measurement).
The
following table summarizes fair value measurements by level at June 30, 2019 and December 31, 2018, measured at fair value on
a recurring basis:
June
30, 2019
|
|
Level
1
|
|
|
Level
2
|
|
|
Level
3
|
|
|
Total
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative
liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,404,074
|
|
|
$
|
1,404,074
|
|
December
31, 2018
|
|
Level
1
|
|
|
Level
2
|
|
|
Level
3
|
|
|
Total
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative
liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,452,469
|
|
|
$
|
1,452,469
|
|
Adoption
of New Accounting Standards
Effective
January 1, 2019, we adopted Accounting Standards Codification 842, Leases (“ASC 842”). Operating lease right-of-use
(“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our
obligation to make lease payments arising from the lease, both of which are recognized based on the present value of the future
minimum lease payments over the lease term at the commencement date. Leases with a lease term of 12 months or less at inception
are not recorded on our consolidated balance sheet and are expensed on a straight-line basis over the lease term in our consolidated
statement of income. The adoption of this standard did not have a significant impact on the financial statements.
NOTE
2 - GOING CONCERN
As
reflected in the accompanying financial statements, the Company had a net loss of $685,035, net cash used in operations of $253,349
and has an accumulated deficit of $12,480,099, for the six months ended June 30, 2019. These factors raise substantial doubt about
the Company’s ability to continue as a going concern.
The
ability of the Company to continue as a going concern is dependent on Management’s plans which include potential asset acquisitions,
mergers or business combinations with other entities, further implementation of its business plan and continuing to raise funds
through debt or equity financings. The Company will likely rely upon related party debt or equity financing in order to ensure
the continuing existence of the business.
The
business plan of the Company is to engage in the design, development, marketing and direct-selling
of commercial grade aeroponics fixtures and supporting systems for use in urban Controlled
Environment Agriculture (“CEA”) and Building Integrated Agriculture (“BIA”).
During the next twelve months, the Company’s strategy is to: complete ongoing product
development; commence product marketing, product assembly and sales; construct a demonstration
CEA and BIA farm; and offer design-build services. The Company’s long-term strategy
is to direct sale, license and franchise their patented technologies and methods.
The
accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and
the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating
to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be
unable to continue as a going concern.
NOTE
3 – ACCOUNTS PAYABLE AND ACCRUED LIABILITEIS
|
|
June
30,
|
|
|
December
31,
|
|
|
|
2019
|
|
|
2018
|
|
Accounts
payable
|
|
$
|
116,396
|
|
|
$
|
45,525
|
|
Revolving
credit
|
|
|
16,577
|
|
|
|
17,198
|
|
Accrued
expenses
|
|
|
47,481
|
|
|
|
59,335
|
|
Accrued
interest
|
|
|
107,681
|
|
|
|
112,641
|
|
|
|
$
|
288,135
|
|
|
$
|
234,699
|
|
NOTE
4 - CONVERTIBLE NOTES PAYABLE
Convertible
notes payable at June 30, 2019 and December 31, 2018 are as follows:
|
|
June
30,
|
|
|
December
31,
|
|
|
|
2019
|
|
|
2018
|
|
Note
1
|
|
$
|
-
|
|
|
$
|
32,027
|
|
Note
2
|
|
|
50,000
|
|
|
|
50,000
|
|
Note
3
|
|
|
420,004
|
|
|
|
550,000
|
|
Note
4
|
|
|
451,050
|
|
|
|
341,050
|
|
Total
convertible notes payable
|
|
|
921,054
|
|
|
|
973,077
|
|
|
|
|
|
|
|
|
|
|
Less:
Unamortized debt discount
|
|
|
(56,503
|
)
|
|
|
(20,826
|
)
|
Total
convertible notes
|
|
|
864,551
|
|
|
|
952,251
|
|
|
|
|
|
|
|
|
|
|
Less:
current portion of convertible notes
|
|
|
864,551
|
|
|
|
952,251
|
|
Long-term
convertible notes
|
|
$
|
-
|
|
|
$
|
-
|
|
Conversion
During
the six months ended June 30, 2019, the Company converted notes with principal amounts and accrued interest of $180,342 into 9,869,021
shares of common stock. The corresponding derivative liability at the date of conversion of $348,823 was settled through additional
paid in capital.
Note
1
On
March 24, 2017, the Company entered into a securities purchase agreement with Tangiers Global, LLC (“Tangiers”) relating
to the issuance and sale of notes (“Note 1”) in the aggregate principal amount of up to $550,000, which includes a
10% original issue discount. Note 1 is convertible into shares of common stock at a price equal to $0.30 per share; provided,
however that if Note 1 is not retired on or before the maturity date, defined in Note 1 as a “Maturity Default” the
conversion price shall be adjusted to be equal to the lower of: (i) $0.30 or (ii) 65% multiplied by the lowest trading price of
the Company’s common stock in the fifteen (15) consecutive trading day period immediately preceding the date that the Company
receives a notice of conversion. The Tangiers Note 1 carries interest on the unpaid principal amount at the rate of 8% per annum
and is due and payable eight months from the effective date of each payment. As of June 30, 2019 and December 31, 2018, the balance
under Note 1 is $917 and $39,997, which $917 and $7,970 in accrued interest, respectively. As of June 30, 2019 and December 31,
2018, Note 1 can be converted into 88,173 and 2,017,525 shares of the Company’s common stock, respectively.
On
October 12, 2017, the Company entered into an Investment Agreement with Tangiers. Pursuant to the terms of the Investment Agreement,
Tangiers committed to purchase up to $2,000,000 of our common stock over a period of up to 36 months. From time to time during
the 36-month period commencing from the effectiveness of the registration statement, we may deliver a put notice to Tangiers which
states the dollar amount that we intend to sell to Tangiers on a date specified in the put notice. The maximum investment amount
per notice must be no more than 200% of the average daily trading dollar volume of our common stock for the eight (8) consecutive
trading days immediately prior to date of the applicable put notice and such amount must not exceed an accumulative amount of
$250,000. The minimum put amount is $5,000. The purchase price per share to be paid by Tangiers will be the 80% of the of the
average of the two lowest closing bid prices of the common stock during the pricing period applicable to the put notice, provided,
however, an additional 10% will be added to the discount of each put if (i) we are not DWAC eligible and (ii) an additional 15%
will be added to the discount of each put if we are under DTC “chill” status on the applicable date of the put notice.
On
October 10, 2017, the Company executed Amendment #1 to the Tangiers Note 1 for a final draw of $250,000 payment plus a 10% original
issue discount. Amendment #1 modified the maturity date for the Tangier Note from eight months to six months from the effective
date of each payment. All other terms and conditions of the Tangiers Note 1 remain effective.
The
execution of Amendment #1 to Note 1 on October 10, 2017 caused the Company to default on the first draw due under Note 1 due to
the acceleration of the maturity date. The default allows Tangiers to demand payment in cash equal to 150% of the outstanding
principal and interest, which is automatically added to the outstanding principle, and convert all or a portion of the outstanding
principal into shares of common stock of the Company. The default conversion rate of Note 1 is now the lower of the conversion
rate then in effect or 65% of the lowest trading price for the 15 days prior to Tangiers’ notice of conversion. As of May
1, 2018, Tangiers has informed the Company that they have elected at this time not to enforce the default interest rate of 18%
under Note 1 and also not to enforce the fees, reserving its rights to enforce the foregoing in their discretion.
Note
2
On
October 12, 2017. the Company issued a fixed convertible promissory note to Tangiers for the principal sum of $50,000 as a commitment
fee for the Investment Agreement. The promissory note (“Note 2”) maturity date is May 12, 2018. The principal amount
due under Note 2 can be converted by Tangiers any time, into shares of the Company’s common stock at a conversion price
of $0.1666 per share. The promissory note is in a “Maturity Default,” which is defined in Note 2 as the event in which
Note 2 is not retired prior to its maturity date, Tangiers’ conversion rights under Note 2 would be adjusted such that the
conversion price would be the lower of (i) $0.1666 or (ii) b) 65% of the average of the two lowest trading prices of the Company’s
common stock during the 10 consecutive trading days prior to the date on which Tangiers elects to convert all or part of the note.
The default interest rate is 20%. As of June 30, 2019 and December 31, 2018, the balance under Note 2 is $60,603 and 61,384, which
includes $5,000 and $5,000 in guaranteed interest and $5,603 and $6,384 in accrued interest, respectively. As of June 30, 2019
and December 31, 2018, Note 2 can be converted into 5,790,965 and 3,096,270 shares of the Company’s common stock, respectively.
Note
3
On
January 16, 2018, the Company issued and sold an 8% Fixed Convertible Promissory Note (“Note 3”) to Tangiers (the
“Buyer”), in the aggregate principal amount of up to $550,000, which includes a 10% original issue discount. Note
3 is convertible into shares of the Company’s common stock at a conversion price of $0.30 per share. However, if Note 3
is not paid back on or before the maturity date, defined in Note 3 as a “Maturity Default”, the conversion price of
Note 3 shall then be adjusted to be equal to the lower of: (i) $0.30 or (ii) 65% multiplied by the lowest trading price of the
Company’s common stock in the fifteen (15) consecutive trading day period immediately preceding the trading day that the
Company receives a notice of conversion of Note 3.
On
February 13, 2018, April 17, 2018, June 13, 2018, and July 27, 2018, the Company executed Amendments #1, #2, #3, and #4 to the
Tangiers Note 3 for draws of $132,000, $132,000, $101,750 and $101,750, respectively. All other terms and conditions of the Tangiers
Note 3 remain effective. As of June 30, 2019 and December 31, 2018, the balance under Note 3 is $475,644 and $616,002, which includes
$37,400 and $44,000 in guaranteed interest and $18,240 and $22,002 in accrued interest. As of June 30, 2019 and December 31, 2018,
Note 3 can be converted into 45,450,912 and 25,528,999 shares of the Company’s common stock.
Note
4
On
September 14, 2018, the Company issued and sold an 8% Fixed Convertible Promissory Note (“Note 4”) to Tangiers (the
“Buyer”), in the aggregate principal amount of up to $550,000, which includes a 10% original issue discount. Note
4 is convertible into shares of the Company’s common stock at a conversion price of $0.08 per share. However, if Note 4
is not paid back on or before the maturity date, defined in Note 4 as a “Maturity Default”, the conversion price of
Note 4 shall then be adjusted to be equal to the lower of: (i) $0.08 or (ii) 65% of the lowest trading price of the Company’s
common stock during the 15 consecutive trading days prior to the date on which Buyer elects to convert all or part of the Note
4.
On
December 14, 2018 and April 2, 2019, the Company executed Amendments #1 and #2 to the Tangiers Note 4 for draws of $171,050 and
$110,000, respectively. All other terms and conditions of the Tangiers Note 4 remain effective. As of June 30, 2019 and December
31, 2018, the balance under Note 4 is $491,572 and $368,334, which includes $36,084 and $27,284 in guaranteed interest and $4,438and
$0 in accrued interest.
Debt
Discount and Original Issuance Costs
The
debt discount amount consists of debt discount due to beneficial conversion features, warrant, original issue costs, and debt
issue costs. The Company amortized debt discount of $74,323 and $109,910 to interest expense during the six months ended June
30, 2019 and 2018, as follows:
|
|
June
30,
|
|
|
December
31,
|
|
|
|
2019
|
|
|
2018
|
|
Debt
discount, beginning of period
|
|
$
|
20,826
|
|
|
$
|
69,541
|
|
Additional
debt discount and debt issue cost
|
|
|
110,000
|
|
|
|
98,300
|
|
Amortization
of debt discount and debt issue cost
|
|
|
(74,323
|
)
|
|
|
(147,015
|
)
|
Debt
discount, end of period
|
|
$
|
56,503
|
|
|
$
|
20,826
|
|
NOTE
5 - DERIVATIVE LIABILITIES
The
Company identified the conversion features embedded within its convertible debts as financial derivatives. The Company has determined
that the embedded conversion option should be accounted for at fair value.
At
June 30, 2019, the estimated fair values of the liabilities measured on a recurring basis are as follows:
|
|
|
Six
months ended
|
|
|
|
|
June
30,
|
|
|
|
|
2019
|
|
Expected
term
|
|
|
0.26
- 0.50
|
|
Expected
average volatility
|
|
|
208%
- 227
|
%
|
Expected
dividend yield
|
|
|
-
|
|
Risk-free
interest rate
|
|
|
2.12%
- 2.45
|
%
|
The
following schedule shows the change in fair value of the derivative liabilities at June 30, 2019:
Fair
Value Measurements Using Significant Observable Inputs (Level 3)
|
|
|
|
|
Balance
- December 31, 2018
|
|
$
|
1,452,469
|
|
Addition
of new derivatives recognized as debt discounts
|
|
|
100,000
|
|
Addition
of new derivatives recognized as options compensation
|
|
|
-
|
|
Addition
of new derivatives recognized as loss on derivatives
|
|
|
936,782
|
|
Settled
on issuance of common stock
|
|
|
(348,823
|
)
|
Gain
on change in fair value of the derivative
|
|
|
(736,354
|
)
|
Balance
- June 30, 2019
|
|
|
1,404,074
|
|
Less:
current portion
|
|
|
(1,404,074
|
)
|
Long-term
derivative liabilities
|
|
$
|
-
|
|
The
aggregate loss on derivatives during the six months ended June 30, 2019 and 2018 was $200,428 and $438,321, respectively.
NOTE
6 - RELATED PARTY TRANSACTIONS
On
January 15, 2018 Ms. Sandra Fowler, was appointed as the Chief Marketing Officer of the Company. Pursuant to the terms of the
Fowler Employment Agreement, Ms. Fowler shall serve as Chief Marketing Officer of the Company. The initial term of the agreement
will expire on January 15, 2019 and commencing on January 15, 2019 and on each anniversary of such date thereafter, the term of
the Fowler Employment Agreement shall automatically renew for a one-year period, unless earlier terminated by either party pursuant
to the terms of the Fowler Employment Agreement. In consideration for Ms. Fowler’s services, under the Fowler Employment
Agreement, Ms. Fowler shall receive (i) an annual base salary of $48,000 and (ii) 200,000 shares of restricted common stock of
the Company. Further, pursuant to the Fowler Employment Agreement, the Company agreed to revise the annual base compensation for
Ms. Fowler to $65,000, after 90 days of the execution of the Fowler Employment Agreement, or after the Company raises not less
than $1,000,000 from sales of its equity securities subsequent to the execution of the Fowler Employment Agreement, whichever
may come first. In addition, Ms. Fowler shall be eligible to participate in any equity-based incentive compensation plan or programs
adopted by the Company’s board of directors. On January 15, 2019, this agreement was terminated.
Weadock
Employment Agreement
On
February 20, 2018, Mr. Daniel Weadock was appointed Chief Executive Officer and Director of the Company. On February 20, 2018,
the Company entered into an executive employment agreement with Mr. Weadock (the “Weadock Employment Agreement”),
pursuant to which Mr. Weadock agreed to act as the Company’s chief executive officer. Pursuant to the terms of the Weadock
Employment Agreement, Mr. Weadock initial will not receive a salary. However, effective on the business day after the date on
which the Company achieves Capitalization (as hereinafter defined) of $2,000,000 or more, Mr. Weadock’s annual base salary
will be $100,000. For purposes of the Weadock Employment Agreement, “Capitalization” means aggregate net cash proceeds
received by the Company from (a) the Company’s sale of common stock pursuant to Puts (as such term is defined in the Investment
Agreement dated as of October 12, 2017 by and between the Company and Tangiers Global, LLC (the “Investment Agreement”))
under the Investment Agreement, and/or (b) any other sale by the Company of common stock or preferred stock, whether in a public
offering or a private placement. In addition, pursuant to the terms of the Weadock Employment Agreement, the Company agreed to
grant Mr. Weadock (i) 300,000 shares of restricted stock as soon as administratively practicable following execution of the Weadock
Employment Agreement, and (ii) 1,584,202 shares of restricted common stock, consistent with the grant and vesting schedule set
forth in the agreement; provided, however, that no grant will be made and no shares will be issued with respect to any grant if
Mr. Weadock is not employed by the Company as an executive on the respective Date of Grant as set forth in the agreement. The
Weadock Employment Agreement has a term of one year, unless Mr. Weadock’s employment is terminated sooner by the board of
directors, and the term will be extended for additional one-year periods unless the Company or Mr. Weadock gives the other party
at least 30 days’ prior written notice of its intent not to renew. On February 20, 2018, the Company also entered into a
compensation agreement with Mr. Weadock (the “Director Compensation Agreement”).Pursuant to the terms of the Director
Compensation Agreement, the Company agreed to grant Mr. Weadock an aggregate of 240,000 shares of restricted common stock, consistent
with the grant and vesting schedule set forth in the agreement; provided, however, that no grant will be made and no shares will
be issued with respect to any grant, if Mr. Weadock is not a member of the Company’s board of directors on the respective
Date of Grant as set forth in the agreement. If the Company is acquired by, or merged into and with, another entity prior to the
last Date of Vesting set forth in the agreement (i.e. February 23, 2022), all shares issuable to Mr. Weadock under the Director
Compensation Agreement will become fully vested and non-forfeitable. The Company also agreed to reimburse Mr. Weadock for all
reasonable travel and incidental expenses incurred by Mr. Weadock in performing his services and attending meetings as approved
in advance by the Company. Also, on February 20, 2018, the Company also entered into an indemnity agreement with Mr. Weadock (the
“Weadock Indemnity Agreement”). Pursuant to the terms of the Indemnity Agreement, the Company agreed to use reasonable
efforts to obtain and maintain in full force and effect directors’ and officers’ liability insurance (“D&O
Insurance”) in reasonable amounts from established and reputable insurers; provided, however, the Company shall have no
obligation to obtain or maintain D&O Insurance if the Company determines in good faith that such insurance is not reasonably
available, the premium costs for such insurance are disproportionate to the amount of coverage provided, the coverage is reduced
by exclusions so as to provide an insufficient benefit, or Mr. Weadock is covered by similar insurance maintained by a subsidiary
of the Company. In addition the foregoing, the Company will indemnify Mr. Weadock from certain third party actions, derivative
actions and actions where Mr. Weadock is decreased; provided, however, the Company shall not be obligated to indemnify Mr. Weadock
for actions including, but not limited to, actions initiated by Mr. Weadock, for any action in which it is determined that the
material assertions made by Mr. Weadock in such proceeding were not made in good faith or were frivolous, for any settlements
not authorized by the Company, for any actions on the account of Mr. Weadock’s willful misconduct, and for any expenses
and the payment of profits arising from the purchase and sale Mr. Weadock of securities in violation of Section 16(b) of the Securities
Exchange Act, or any similar successor statute; provided, further that, that the Company shall not be obligated to indemnify Mr.
Weadock for expenses or liabilities of any type whatsoever which have been paid directly to Mr. Weadock pursuant to the Company’s
D&O Insurance policy.
Effective
May 15, 2019, the Registrant mutually and amicably arranged with departing officer and Director Daniel Weadock, for him to transition
to becoming an advisor to the Registrant. Thus, Mr. Weadock no longer serves in any officer or Director capacity. As part of a
non-material arrangement, subject to the Board monthly requests, Mr. Weadock focuses include consulting on potential acquisitions,
among other things. The Board confirmed typical consulting arrangements to apply moving forward, including some shares of common
stock, 100,000, potential future stock and other considerations, indemnifications and reimbursement of expenses.
Management
Effective
May 15, 2019, the Board of Directors has appointed Thomas Cook to act as interim principal accounting officer and principal executive
officer serving in the capacity of interim CEO and interim CFO with non-material arrangements to apply moving forward, including
compensation of $5,000 and 10,000 shares monthly, potential stock and other considerations, indemnifications and reimbursement
of expenses. Mr. Cook owns no Company securities at this time. While Mr. Cook is acting CEO and CFO, the Company sees him serving
in a limited role while it is actively seeking new CEO and CFO candidates to serve on long term basis, with education and experiences
to fit the Company 2019 plans.
NOTE
7 - SHAREHOLDERS’ EQUITY
Convertible
Series A Preferred Stock
As
at June 30, 2019 and December 31, 2018, there were 750,000 shares of Series A Convertible Preferred Stock issued and outstanding.
Common
Stock
During
the six months ended June 30, 2019, the Company issued 12,373,351 shares of common stock as follows;
|
●
|
2,245,318
shares valued at $64,866 for consulting services
|
|
●
|
129,012
shares valued at $6,179 pursuance to Weadock Employment Agreement (Note6)
|
|
●
|
100,000
shares valued at $3,690 for a termination of Weadock Employment Agreement (Note 6)
|
|
●
|
30,000
shares valued at $819 for a management compensation (Note 6)
|
|
●
|
9,869,021
shares for conversion of debt of $180,342 (Note 4)
|
Common
Stock Warrants and option
As
of June 30, 2019, no warrants or options were outstanding.
NOTE
9 - COMMITMENTS & CONTINGENCIES
On
February 20, 2014, the Company signed a 60-month lease on a 10,000 sq. ft. office/warehouse facility and paid a deposit of $12,600.
The monthly base rent is $4,200 increasing 6% every two years for the term of the lease. The property is adequate for all of the
Company’s currently planned activities.
Deferred
rent payable at June 30, 2019 and December 31, 2018 was $0 and $1,826, respectively. Deferred rent payable is the sum of the difference
between the monthly rent payment and the straight-line monthly rent expense of an operating lease that contains escalated payments
in future periods.
Rent
expense for the six months ended June 30, 2019 and 2018, were $17,050 and $21,308, respectively
NOTE
10 - SUBSEQUENT EVENTS
Subsequent
to June 30, 2019, the Company issued 1,433,349 shares for conversion of debt of $15,000.